 |
 |
 |
|
Comparison of Long-Acting Lenacapavir Phase 2/3 Regimen vs Simplified Regimen Using Population-PK Analysis and Simulation
|
|
|
IAS 2023 july 25
Naveed A. Shaik,1 Francesco Bellanti,2 Kishore Pollireddy,2 Vamshi Jogiraju,1 Craig Comisar,2 Sandhya Girish,1 Martin Rhee,1 Ramesh Palaparthy,1 Renu Singh1
1Gilead Sciences, Inc., Foster City, California, USA; 2Certara, Inc., Princeton, New Jersey, USA







|
|
|
 |
 |
|
|